Phillips 66
PSX
271.62
+1.83
+0.68%
Phillips 66
US · PSX
#204 by market cap
Listed 1970
271.62
+1.83
+0.68%
Live - 5344 symbols - heartbeat 27s ago
· 2026-10-08 08:28
Pre-market
275.56
+1.45%
After-hours
271.62
0.00%
Overnight
273.41
+0.66%
- Market cap
- 108.38B
- P/E (TTM)i
- 15.50
- P/Bi
- 3.44
- EPSi
- 10.79
- Div yieldi
- 1.82%
- 52W posi
- 96%
Reader sentiment
Are you bullish or bearish on PSX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.14, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -7.53% YoY
Margins
- Gross margin
- 9.84%
- Operating margin
- 2.55%
- Net margin
- 3.32%
Key ratios & quality
- Enterprise valuei
- 126.98B
- Altman Z-Scorei
- 4.14
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 111.46B | 107.29B | 64.13B | 111.48B | 169.99B | 147.40B | 143.15B | 132.38B |
| Gross profit | 12.18B | 10.42B | 5.03B | 7.77B | 18.43B | 17.34B | 10.83B | 13.03B |
| Selling & admin expenses | 1.68B | 1.68B | 1.54B | 1.74B | 2.17B | 2.53B | 2.81B | 2.44B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 5.19B | 3.26B | -1.54B | 468.00M | 9.62B | 7.95B | 1.75B | 3.38B |
| Pretax profit | 7.45B | 4.18B | -4.96B | 1.74B | 14.64B | 9.47B | 2.68B | 5.42B |
| Tax | 1.57B | 801.00M | -1.25B | 146.00M | 3.25B | 2.23B | 500.00M | 892.00M |
| Net profit | 5.87B | 3.38B | -3.71B | 1.59B | 11.39B | 7.24B | 2.18B | 4.53B |
| Basic EPS | 12 | 7 | -9 | 3 | 23 | 16 | 5 | 11 |
| Diluted EPS | 11.80 | 6.77 | -9.06 | 2.97 | 23.27 | 15.48 | 4.99 | 10.79 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 30.43B | 33.32B | 34.52B | 34.11B | 32.54B | 51.00B |
| Gross profit | 1.98B | 3.43B | 3.47B | 4.15B | 2.77B | 6.76B |
| Selling & admin expenses | 519.00M | 582.00M | 792.00M | 544.00M | 537.00M | 538.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -395.00M | 1.19B | 965.00M | 1.62B | 114.00M | 4.28B |
| Pretax profit | 648.00M | 1.12B | 199.00M | 3.45B | 260.00M | 4.97B |
| Tax | 122.00M | 212.00M | 32.00M | 526.00M | 41.00M | 1.09B |
| Net profit | 526.00M | 908.00M | 167.00M | 2.93B | 219.00M | 3.88B |
| Basic EPS | 1 | 2 | 0 | 7 | 1 | 10 |
| Diluted EPS | 1.18 | 2.15 | 0.32 | 7.17 | 0.51 | 9.55 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 13.21B | 14.40B | 13.28B | 14.70B | 21.92B | 19.94B | 17.91B | 17.27B |
| Cash & ST investments | 3.02B | 1.61B | 2.51B | 3.15B | 6.13B | 3.32B | 1.74B | 1.12B |
| Inventory | 3.54B | 3.78B | 3.89B | 3.39B | 3.28B | 3.75B | 4.00B | 5.10B |
| Total assets | 54.30B | 58.72B | 54.72B | 55.59B | 76.44B | 75.50B | 72.58B | 73.68B |
| Total current liabilities | 8.94B | 11.65B | 9.52B | 12.80B | 15.89B | 15.86B | 15.09B | 13.33B |
| Short-term debt | 67.00M | 547.00M | 987.00M | 1.49B | 529.00M | 1.48B | 1.83B | 1.04B |
| Long-term debt | 11.09B | 11.22B | 14.91B | 12.96B | 16.66B | 17.88B | 18.23B | 18.68B |
| Total liabilities | 27,149,000,000.00 | 31,551,000,000.00 | 33,198,000,000.00 | 33,957,000,000.00 | 42,336,000,000.00 | 43,851,000,000.00 | 44,119,000,000.00 | 43,439,000,000.00 |
| Total equity | 27.15B | 27.17B | 21.52B | 21.64B | 34.11B | 31.65B | 28.46B | 30.24B |
| Retained earnings | 20.49B | 22.06B | 16.50B | 16.22B | 25.43B | 30.55B | 30.77B | 33.24B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 18.28B | 21.08B | 22.02B | 17.27B | 27.40B | 24.22B |
| Cash & ST investments | 1.49B | 1.05B | 1.85B | 1.12B | 5.15B | 4.10B |
| Inventory | 5.24B | 5.58B | 6.42B | 5.10B | 6.72B | 5.92B |
| Total assets | 71.84B | 75.94B | 76.12B | 73.68B | 84.08B | 81.81B |
| Total current liabilities | 14.88B | 19.69B | 17.95B | 13.33B | 24.19B | 18.35B |
| Short-term debt | 1.06B | 3.74B | 2.59B | 1.04B | 8.45B | 1.80B |
| Long-term debt | 17.74B | 17.20B | 19.17B | 18.68B | 18.68B | 18.77B |
| Total liabilities | 43,485,000,000.00 | 47,315,000,000.00 | 48,039,000,000.00 | 43,439,000,000.00 | 54,403,000,000.00 | 49,107,000,000.00 |
| Total equity | 28.35B | 28.63B | 28.08B | 30.24B | 29.68B | 32.70B |
| Retained earnings | 30.79B | 31.17B | 30.82B | 33.24B | 32.93B | 36.27B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 7.57B | 4.81B | 2.11B | 6.02B | 10.81B | 7.03B | 4.19B | 4.96B |
| Depreciation & amortization | 1.36B | 1.34B | 1.40B | 1.61B | 1.63B | 1.98B | 2.36B | 3.25B |
| Free cash flow | 4.93B | 935.00M | -809.00M | 4.16B | 8.93B | 4.87B | 2.33B | 2.73B |
| Dividends paid | -1.44B | -1.57B | -1.58B | -1.59B | -1.79B | -1.88B | -1.88B | -1.92B |
| Stock buybacks / issuance | -4.48B | -1.45B | -433.00M | 26.00M | -1.41B | -3.89B | -3.37B | -1.10B |
| Ending cash balance | 3.02B | 1.61B | 2.51B | 3.15B | 6.13B | 3.32B | 1.74B | 1.12B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 187.00M | 845.00M | 1.18B | 2.75B | -2.26B | 7.26B |
| Depreciation & amortization | 791.00M | 816.00M | 826.00M | 818.00M | 558.00M | 585.00M |
| Free cash flow | -236.00M | 258.00M | 637.00M | 2.07B | -2.85B | 6.53B |
| Dividends paid | -469.00M | -487.00M | -484.00M | -482.00M | -509.00M | -508.00M |
| Stock buybacks / issuance | -224.00M | -417.00M | -199.00M | -260.00M | -185.00M | -362.00M |
| Ending cash balance | 1.49B | 1.14B | 1.95B | 1.12B | 5.15B | 4.10B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 22.47 | 12.39 | -18.15 | 6.85 | 45.27 | 23.32 | 7.27 | 15.55 |
| ROA %i | 10.29 | 5.43 | -7.02 | 2.37 | 16.68 | 9.22 | 2.85 | 6.01 |
| ROIC %i | 16.81 | 9.45 | -10.07 | 5.40 | 28.52 | 15.54 | 5.64 | 10.77 |
| 5-year avg ROE %i | 18.30 | 16.41 | 9.00 | 9.01 | 13.77 | 13.93 | 12.91 | 19.65 |
| EBIT margin %i | 7.15 | 4.34 | -6.93 | 2.10 | 8.99 | 7.05 | 2.53 | 4.91 |
| FCF / sales %i | 4.43 | 0.87 | -- | 3.73 | 5.07 | 3.13 | 1.63 | 2.06 |
| Current ratioi | 1.48 | 1.24 | 1.39 | 1.15 | 1.38 | 1.26 | 1.19 | 1.30 |
| Quick ratioi | 1.03 | 0.87 | 0.95 | 0.83 | 1.08 | 0.95 | 0.85 | 0.82 |
| Debt / assetsi | 20.55 | 20.03 | 29.04 | 25.99 | 22.49 | 25.64 | 27.64 | 26.76 |
| LT debt / equityi | 45.00 | 45.03 | 78.52 | 67.61 | 56.49 | 58.45 | 66.52 | 64.20 |
| Interest coveragei | 15.13 | 9.69 | -8.53 | 3.88 | 23.80 | 11.23 | 3.82 | 5.99 |
| Revenue CAGR (3Y) %i | 4.04 | 8.38 | -14.43 | 0.00 | 16.58 | 31.97 | 8.69 | -8.00 |
| Net income CAGR (3Y) %i | 9.80 | 25.53 | -- | -38.29 | 53.03 | -- | 17.20 | -26.36 |
| FCF CAGR (3Y) %i | -- | 98.80 | -- | -5.55 | 112.13 | -- | -17.53 | -32.63 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 6.48 | 6.00 | 5.38 | 15.55 | 14.75 | 24.02 |
| ROA %i | 2.49 | 2.25 | 1.98 | 6.01 | 5.28 | 8.98 |
| ROIC %i | 5.47 | 5.18 | 4.80 | 10.77 | 9.99 | 16.04 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 2.40 | 2.37 | 2.25 | 4.91 | 4.60 | 6.63 |
| FCF / sales %i | 2.15 | 1.12 | 1.02 | 2.06 | 0.09 | 4.20 |
| Current ratioi | 1.23 | 1.07 | 1.23 | 1.30 | 1.13 | 1.32 |
| Quick ratioi | 0.79 | 0.63 | 0.69 | 0.82 | 0.71 | 0.86 |
| Debt / assetsi | 26.17 | 27.57 | 28.58 | 26.76 | 32.26 | 25.14 |
| LT debt / equityi | 65.05 | 62.57 | 71.21 | 64.20 | 65.47 | 59.57 |
| Interest coveragei | 3.50 | 3.22 | 2.93 | 5.99 | 5.37 | 8.38 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Refining is the largest reported line at 70.45% of revenue, across 6 reported segments.
- The next-largest line, Marketing and Specialties (M&S), is a distant second at 62.91% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Refining70.45%
Marketing and Specialties (M&S)62.91%
Midstream12.35%
Renewable Fuels5.03%
Quote time 2026-10-08 08:28:00 · For reference only, not investment advice and not tailored to your situation.